Easom Eric - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 15, 2024, Easom Eric's relationship to AN2 Therapeutics, Inc. (ANTX) is Director,Officer (Chief Executive Officer), and currently has 101,130 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Easom Eric - Insider Non-Derivative Transactions of ANTX Common Stock
Easom Eric - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 16, 2024 | Acquisition -- (Common Stock) | 99000 | 0 | 101130 |
| Jan 3, 2024 | Sell -- (Common Stock) | 2777 | 20.09 | 2130 |
| May 16, 2023 | P -- (Common Stock) | 10000 | 5.38 | 1015766 |